Exclusive Member Briefing Sessions on In Silico Methods in Emerging European Health Policy and Regulation

The sustained efforts of the in silico medicine community, including by the VPH Society and its industrial partners of the Avicenna Alliance, across meetings, collaborative projects, conferences, and scientific publications, are now translating into policy impact that surpasses expectations. In a series of legal text proposals released in December 2025 by the European Commission, in silico approaches – well beyond AI alone – are explicitly positioned as essential tools across the full life cycle of medical therapies.

These developments span multiple strategic initiatives, including breakthrough pathways under the current Medical Device Regulation, the proposed MDR revision, the Biotech Act, and the European Cardiovascular Plan. Together, they signal a decisive shift in how in silico medicine and digital technologies are recognised within Europe’s regulatory and innovation frameworks.

To analyse these changes in depth, the VPH Society is organising two exclusive online briefing sessions, open only to VPH Society members and industry members of the Avicenna Alliance, at the end of January. These briefings are intended as strategic moments for a community that has helped shape the current policy landscape – and whose continued engagement will be critical in determining its final outcome.

These briefing sessions will:

• Examine the fine print of the newly released policy and regulatory proposals;
• Provide a clear overview of the most important changes and their potential implications;
• Reflect on the collective journey that led to this moment;
• Outline the actions still required, particularly during the parliamentary phase, to ensure that positive elements are retained;
• Discuss how members can actively contribute going forward.

The two meetings are complementary in scope:

• 21 January – 14 /15.30 CET: Emergence of In Silico in Health Policy & Regulatory Science – Register now
• 27 January – 14 / 15.30 CET: In Silico as Regulatory Evidence in EU – Register now

All registration requests will be reviewed and access will be granted exclusively to VPH Society members and industry members of the Avicenna Alliance.

———————

If you are already a VPH member, please ensure that your membership is renewed for 2026 by logging into your personal account.

If you are not yet a member, we invite you to explore our membership plans and the associated benefits here.